AW
MRNA icon

Avion Wealth’s Moderna MRNA Stock Holding History

Avion Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
171
-18
-10% -$931 ﹤0.01% 577
2026
Q1 		$9K Buy
189
+53
+39% +$2.47K ﹤0.01% 522
2025
Q4 		$4K Buy
136
+80
+143% +$2.17K ﹤0.01% 713
2025
Q3 		$1K Sell
56
-75
-57% -$2.09K ﹤0.01% 1058
2025
Q2 		$3K Buy
131
+119
+992% +$3.13K ﹤0.01% 732
2025
Q1 		$0 Buy
+12
New +$426 ﹤0.01% 1236
2024
Q4 		– Sell
-31
Closed -$2K – 1180
2024
Q3 		$2K Sell
31
-23
-43% -$2.11K ﹤0.01% 701
2024
Q2 		$6K Sell
54
-20
-27% -$2.53K ﹤0.01% 435
2024
Q1 		$8K Buy
74
+8
+12% +$806 ﹤0.01% 357
2023
Q4 		$7K Buy
66
+37
+128% +$3.11K ﹤0.01% 333
2023
Q3 		$2K Buy
29
+25
+625% +$2.79K ﹤0.01% 502
2023
Q2 		$0 Buy
+4
New +$534 ﹤0.01% 929

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Avion Wealth's MRNA Position: Q2 2026 in Review

Avion Wealth reduced its Moderna (MRNA) stake by 9.5% in Q2 2026, selling an estimated $931 and leaving 171 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Avion Wealth first reported a position in MRNA in Q2 2023 and has held it in 12 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Avion Wealth held 171 shares of Moderna worth $11K as of Q2 2026.
  • Avion Wealth sold 18 Moderna shares in Q2 2026, an estimated $931.
  • Moderna made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #577 holding.
  • Avion Wealth first reported a position in Moderna in Q2 2023 and has held it in 12 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.